Chromosome,Position,Ref,Alt,rsID,Beta Score,P-value,Odds ratio,Gene Name,Function,Citation,LInks
16,68710036,A,C,rs9924886,-,3 x 10-8,1.06,CDH3,"This gene is a cell adhesion molecule important for tissue integrity. It's abundant in the placenta and often overexpressed in cancer, including colorectal cancer. This study examined its expression in CRC tissues and normal tissues, along with plasma CDH3 levels, to understand its relationship with cancer stage.","Kumara, H. M. C. S., Bellini, G. A., Caballero, O. L., Herath, S. A. C., Su, T., Ahmed, A., Njoh, L., Cekic, V., & Whelan, R. L. (2017). P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring. Oncoscience, 4(9-10), 139?147. https://doi.org/10.18632/oncoscience.370",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672898/
11,102525876,T,"A,C",rs12285347,0.0775,1 x 10-8,-,MMP7,"This gene encodes for matrix metalloproteinase-7, which is involved in breaking down extracellular matrix proteins. In cancer, MMP7 promotes tumor invasion and metastasis, and its overexpression is associated with poor prognosis, particularly in basal-like breast cancer subtypes. ","Sizemore, S.T., Sizemore, G.M., Booth, C.N. et al. Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors. Breast Cancer Res Treat 146, 25?40 (2014). https://doi.org/10.1007/s10549-014-2989-4",https://link.springer.com/article/10.1007/s10549-014-2989-4
11,102836608,C,"A,T",rs639752,-,1 x 10-6,-,MMP3,"This gene encodes matrix metalloproteinase-3 (MMP3), also known as stromelysin-1. It's implicated in breast, lung, and pancreatic cancers, promoting tumor progression by inducing the expression of Rac1b, a tumorigenic isoform of Rac1. Overexpression of MMP3 is associated with poor prognosis in these cancers.","Mehner, C., Miller, E., Nassar, A., Bamlet, W. R., Radisky, E. S., & Radisky, D. C. (2015). Tumor cell expression of MMP3 as a prognostic factor for poor survival in pancreatic, pulmonary, and mammary carcinoma. Genes & cancer, 6(11-12), 480?489. https://doi.org/10.18632/genesandcancer.90",https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701227/
16,89620999,C,"G,T",rs2280374,-,2 x 10-17,1.09864,DPEP1,"This gene encodes dipeptidase 1, an enzyme involved in leukotriene conversion and neutrophil recruitment. In colorectal cancer (CRC), higher DPEP1 expression is associated with worse survival and correlates with increased M2 macrophage infiltration, suggesting a subtype of CRC with potential susceptibility to immunotherapies.","McIver, C. M., Lloyd, J. M., Hewett, P. J., & Hardingham, J. E. (2004). Dipeptidase 1: a candidate tumor-specific molecular marker in colorectal carcinoma. Cancer letters, 209(1), 67?74. https://doi.org/10.1016/j.canlet.2003.11.033",https://www.sciencedirect.com/science/article/abs/pii/S0304383503008292
6,1318643,C,"G,T",rs11242675,-,1 x 10-7,1.0416667,FOXQ1,"The FOXQ1 gene, a member of the forkhead transcription factor family, is overexpressed in colorectal cancer (CRC). It promotes tumor growth by upregulating genes associated with positive roles in tumor growth and enhancing angiogenesis and inhibiting apoptosis. FOXQ1's tumorigenic effects are independent of p21 regulation.","Kaneda, H., Arao, T., Tanaka, K., Tamura, D., Aomatsu, K., Kudo, K., Sakai, K., De Velasco, M. A., Matsumoto, K., Fujita, Y., Yamada, Y., Tsurutani, J., Okamoto, I., Nakagawa, K., & Nishio, K. (2010). FOXQ1 is overexpressed in colorectal cancer and enhances tumorigenicity and tumor growth. Cancer research, 70(5), 2053?2063. https://doi.org/10.1158/0008-5472.CAN-09-2161",https://pubmed.ncbi.nlm.nih.gov/20145154/
5,174713048,C,T,rs192597222,-,1 x 10-6,7.73,MSX2,"The MSX2 gene, found on chromosome 5, is associated with craniosynostosis, a condition where cranial sutures fuse prematurely, leading to abnormal skull shape. Mutations in MSX2 have been linked to this disorder, with affected individuals showing specific genetic markers and histidine substitutions","Jabs, E. W., MÅller, U., Li, X., Ma, L., Luo, W., Haworth, I. S., Klisak, I., Sparkes, R., Warman, M. L., & Mulliken, J. B. (1993). A mutation in the homeodomain of the human MSX2 gene in a family affected with autosomal dominant craniosynostosis. Cell, 75(3), 443?450. https://doi.org/10.1016/0092-8674(93)90379-5",https://pubmed.ncbi.nlm.nih.gov/8106171/
11,2207722,C,"A,T",rs7126629,-,2 x 10-8,1.44,ASCL2,"ASCL2 gene, activated by Wnt/?-catenin signaling, plays a key role in colorectal cancer (CRC) progression. Its increase in expression, triggered by L1 overexpression, enhances CRC cell motility, tumorigenesis, and metastasis. ASCL2 upregulation by L1 activates ?-catenin-LEF1/TCF transactivation, promoting CRC progression.","Basu, S., Gavert, N., Brabletz, T., & Ben-Ze'ev, A. (2018). The intestinal stem cell regulating gene ASCL2 is required for L1-mediated colon cancer progression. Cancer letters, 424, 9?18. https://doi.org/10.1016/j.canlet.2018.03.022",https://pubmed.ncbi.nlm.nih.gov/29551399/
1,62207365,C,T,rs7542665,-,4 x 10-8,1.08,L1TD1,"The L1TD1 gene is frequently downregulated in non-small cell lung cancer (NSCLC) due to tumor-specific DNA methylation. Its re-expression after epigenetic treatment inhibits tumor cell growth and proliferation, indicating its role as a tumor suppressor gene in NSCLC.","Altenberger, C., Heller, G., Ziegler, B., Tomasich, E., Marhold, M., Topakian, T., MÅllauer, L., Heffeter, P., Lang, G., End-PfÅtzenreuter, A., Dîme, B., Arns, B. M., Klepetko, W., Zielinski, C. C., & Zîchbauer-MÅller, S. (2017). SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers. Molecular cancer, 16(1), 1. https://doi.org/10.1186/s12943-016-0568-5",https://pubmed.ncbi.nlm.nih.gov/28093071/
3,10265247,T,G,rs2544001,,5 x 10-6,0.74,TATDN2,"The TATDN2 gene plays a critical role in resolving R-loops and maintaining genomic stability, particularly in BRCA1-deficient cells. TATDN2 exhibits RNA 3? exonuclease and endonuclease activity, targeting double-stranded RNA structures. Depletion of TATDN2 increases cellular R-loops, DNA damage, and chromosomal instability, making it essential for the survival of BRCA1-deficient cancer cells. Therefore, TATDN2 represents a potential therapeutic target for BRCA1-deficient cancers.","Jaiswal, A. S., Dutta, A., Srinivasan, G., Yuan, Y., Zhou, D., Shaheen, M., Sadideen, D. T., Kirby, A., Williamson, E. A., Gupta, Y. K., Olsen, S. K., Xu, M., Loranc, E., Mukhopadhyay, P., Pertsemlidis, A., Bishop, A. J. R., Sung, P., Nickoloff, J. A., & Hromas, R. (2023). TATDN2 resolution of R-loops is required for survival of BRCA1-mutant cancer cells. Nucleic acids research, 51(22), 12224?12241. https://doi.org/10.1093/nar/gkad952",https://pubmed.ncbi.nlm.nih.gov/37953292/
3,190245452,T,C,rs117143670,-,5 x 10-6,3.45,CLDN1,"CLDN1 gene regulates tight junctions and influences cancer cell migration. High CLDN1 expression predicts better prognosis in colorectal cancer patients. Knocking down CLDN1 increases cell invasiveness, indicating its role in cancer progression.","Nakagawa, S., Miyoshi, N., Ishii, H., Mimori, K., Tanaka, F., Sekimoto, M., Doki, Y., & Mori, M. (2011). Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. International journal of oncology, 39(4), 791?796. https://doi.org/10.3892/ijo.2011.1102",https://www.spandidos-publications.com/10.3892/ijo.2011.1102
15,53386924,G,"A,C",rs1038553,-,1 x 10-5,0.27,WDR72,"WDR72 is a scaffolding protein critical for cell functions like growth, adhesion, and migration. In non-small-cell lung cancer (NSCLC), it's highly expressed and linked to better prognosis. It also influences immune cell infiltration and the tumor microenvironment.","Shi, G., Ni, Q., Miao, Y., Huang, H., Yin, Z., Shi, W., & Shi, M. (2023). Identification of WD-Repeat Protein 72 as a Novel Prognostic Biomarker in Non-Small-Cell Lung Cancer. Mediators of inflammation, 2023, 2763168. https://doi.org/10.1155/2023/2763168",https://pubmed.ncbi.nlm.nih.gov/37197572/
4,4870660,G,A,rs116521001,0.366,2 x 10-6,-,MSX1,"MSX1 gene's hypomethylation is linked to poor response in high-grade serous ovarian cancer patients. Its decreased expression is associated with cisplatin resistance, while its overexpression enhances cisplatin sensitivity, promoting apoptosis and p21 expression","Bonito, N. A., Borley, J., Wilhelm-Benartzi, C. S., Ghaem-Maghami, S., & Brown, R. (2016). Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 22(12), 3097?3104. https://doi.org/10.1158/1078-0432.CCR-15-1669",https://pubmed.ncbi.nlm.nih.gov/26763252/
1,200705097,T,"A,C",rs115456075,-,3 x 10-6,8.51,CAMSAP2,"The CAMSAP2 gene is implicated in lung cancer metastasis. High CAMSAP2 expression correlates with poor survival in lung cancer patients and promotes cell migration in non-small cell lung cancer (NSCLC) cell lines. Knockdown of CAMSAP2 inhibits cancer cell motility in vitro and metastasis in vivo. CAMSAP2 interacts with RASAL2, leading to its degradation and activation of the ERK signaling pathway, thereby facilitating lung cancer metastasis.","Singharajkomron, N., Yodsurang, V., Limprasutr, V., Wattanathamsan, O., Iksen, I., Hayakawa, Y., & Pongrakhananon, V. (2024). CAMSAP2 enhances lung cancer cell metastasis by mediating RASAL2 degradation. Life sciences, 338, 122391. https://doi.org/10.1016/j.lfs.2023.122391",https://pubmed.ncbi.nlm.nih.gov/38159595/
16,54286285,G,T,rs3751723,-,2 x 10-9,1.03,IRX3,"IRX3, typically expressed in developing tissues, is implicated in human acute leukemia. Elevated IRX3 levels, found in a significant proportion of leukemia patients, correlate with increased HOXA gene expression. IRX3 alone can immortalize hematopoietic cells and induce leukemia. Its overexpression inhibits normal cell differentiation, contributing to the differentiation block seen in acute leukemias.","Somerville, T. D. D., Simeoni, F., Chadwick, J. A., Williams, E. L., Spencer, G. J., Boros, K., Wirth, C., Tholouli, E., Byers, R. J., & Somervaille, T. C. P. (2018). Derepression of the Iroquois Homeodomain Transcription Factor Gene IRX3 Confers Differentiation Block in Acute Leukemia. Cell reports, 22(3), 638?652. https://doi.org/10.1016/j.celrep.2017.12.063",https://pubmed.ncbi.nlm.nih.gov/29346763/
2,79121070,G,T,rs2070707,-,2 x 10-6,0.2518,REG1A,"REG1A gene shows higher expression in post-menopausal ovarian cancer samples and maintains constant expression in late-stage tumors, suggesting its potential as a biomarker for ovarian cancer diagnosis, especially in post-menopausal individuals and late-stage cases.","Wadapurkar, R. M., Sivaram, A., & Vyas, R. (2023). RNA-Seq Analysis of Clinical Samples from TCGA Reveal Molecular Signatures for Ovarian Cancer. Cancer investigation, 41(4), 394?404. https://doi.org/10.1080/07357907.2023.2182123",https://pubmed.ncbi.nlm.nih.gov/36797673/
8,19966981,T,"A,C",rs13702,0.109,1 x 10-10,-,LPL,The LPL gene's rs13702 variant is linked to a reduced risk of hepatocellular carcinoma (HCC) in alcohol-associated liver disease (ALD) patients. Higher LPL expression in ALD cirrhosis suggests its involvement in disease progression. This variant may serve as a biomarker for HCC risk in ALD patients.,"Schmalz, F., Fischer, J., Innes, H., Buch, S., Mîller, C., Matz-Soja, M., von Schînfels, W., KrÑmer, B., Langhans, B., KlÅners, A., Soyka, M., Stickel, F., Nattermann, J., Strassburg, C. P., Berg, T., Lutz, P., & Nischalke, H. D. (2023). High producer variant of lipoprotein lipase may protect from hepatocellular carcinoma in alcohol-associated cirrhosis. JHEP reports : innovation in hepatology, 5(4), 100684. https://doi.org/10.1016/j.jhepr.2023.100684",https://pubmed.ncbi.nlm.nih.gov/36879887/
2,191052644,T,C,rs113702517,-,9 x 10-7,0.676,STAT4,"The STAT4 gene, involved in development and immune defense, was found to be overexpressed in colorectal cancer tissues. Higher STAT4 levels correlated with advanced cancer stage and invasion depth. Silencing STAT4 suppressed cancer cell growth and invasion, indicating its potential as a therapeutic target for colorectal cancer.","Cheng, J. M., Yao, M. R., Zhu, Q., Wu, X. Y., Zhou, J., Tan, W. L., & Zhan, S. H. (2015). Silencing of stat4 gene inhibits cell proliferation and invasion of colorectal cancer cells. Journal of biological regulators and homeostatic agents, 29(1), 85?92.",https://pubmed.ncbi.nlm.nih.gov/25864744/
2,203869764,C,T,rs231779,-,1 x 10-14,1.0638298,CTLA4,"The CTLA4 gene encodes a protein critical for regulating immune responses in autoimmunity and cancer. Variants in CTLA4, like the +49 A/G polymorphism, influence its expression and function. Certain genotypes may increase susceptibility to autoimmune disorders, while others may heighten the risk of cancer development. This suggests a spectrum of CTLA4 SNPs impacting immune balance and disease predisposition.","Ghaderi A. (2011). CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian journal of immunology : IJI, 8(3), 127?149.",https://pubmed.ncbi.nlm.nih.gov/21931200/
2,203876143,C,"A,G,T",rs231726,-,3 x 10-16,1.0752687,CTLA4,"The CTLA4 gene encodes a protein critical for regulating immune responses in autoimmunity and cancer. Variants in CTLA4, like the +49 A/G polymorphism, influence its expression and function. Certain genotypes may increase susceptibility to autoimmune disorders, while others may heighten the risk of cancer development. This suggests a spectrum of CTLA4 SNPs impacting immune balance and disease predisposition.","Ghaderi A. (2011). CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian journal of immunology : IJI, 8(3), 127?149.",https://pubmed.ncbi.nlm.nih.gov/21931200/
2,203879078,T,A,rs231729,0.0764,3 x 10-14,-,CTLA4,"The CTLA4 gene regulates immune responses, including immune checkpoint modulation. In this melanoma study, while CTLA4 is not directly examined, immune checkpoint molecules like PD-1, PD-L1, and CTLA4 show differential expression in groups classified by a ferroptosis-related gene signature. This suggests a potential link between CTLA4, immune checkpoints, and ferroptosis pathways in melanoma progression and therapy.","Ping, S., Wang, S., Zhao, Y., He, J., Li, G., Li, D., Wei, Z., & Chen, J. (2022). Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma. Cancer medicine, 11(18), 3529?3541. https://doi.org/10.1002/cam4.4706",https://pubmed.ncbi.nlm.nih.gov/35373463/
10,50886333,G,"A,T",rs10821905,0.0634,5 x 10-12,-,A1CF,"The A1CF gene regulates posttranscriptional ApoB mRNA editing and influences hepatic functions, including proliferation, lipogenesis, inflammation, and the development of hepatocellular carcinoma (HCC).","Blanc, V., Riordan, J. D., Soleymanjahi, S., Nadeau, J. H., Nalbantoglu, I., Xie, Y., Molitor, E. A., Madison, B. B., Brunt, E. M., Mills, J. C., Rubin, D. C., Ng, I. O., Ha, Y., Roberts, L. R., & Davidson, N. O. (2021). Apobec1 complementation factor overexpression promotes hepatic steatosis, fibrosis, and hepatocellular cancer. The Journal of clinical investigation, 131(1), e138699. https://doi.org/10.1172/JCI138699",https://pubmed.ncbi.nlm.nih.gov/33445170/
10,50888694,C,T,rs10821907,-,5 x 10-10,1.08,A1CF,The A1CF gene is among nine RNA binding proteins (RBPs) identified as dysregulated in lung squamous cell carcinoma (LUSC). It plays a role in mRNA processes and has prognostic value for LUSC outcomes.,"Li, W., Li, X., Gao, L. N., & You, C. G. (2020). Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma. Frontiers in genetics, 11, 185. https://doi.org/10.3389/fgene.2020.00185",https://pubmed.ncbi.nlm.nih.gov/32194639/
10,50837871,C,T,rs4488147,-,1 x 10-15,-,A1CF,"The A1CF gene acts as a positive regulator of Axin2 in Wilms tumor-derived cells, impacting apoptosis and migration through the Wnt/?-catenin pathway.","Ni, D., Liu, J., Hu, Y., Liu, Y., Gu, Y., Zhou, Q., & Xie, Y. (2019). A1CF-Axin2 signal axis regulates apoptosis and migration in Wilms tumor-derived cells through Wnt/?-catenin pathway. In vitro cellular & developmental biology. Animal, 55(4), 252?259. https://doi.org/10.1007/s11626-019-00335-6",https://pubmed.ncbi.nlm.nih.gov/30825095/
8,29486945,A,"C,G",rs12548021,-,3 x 10-6,1.28,DUSP4,"DUSP4 gene mediates Lenvatinib resistance in hepatocellular carcinoma by activating the MAPK/ERK signaling pathway. Its deficiency enhances cancer cell survival, proliferation, and migration during Lenvatinib treatment, both in vitro and in vivo.","Huang, S., Ma, Z., Zhou, Q., Wang, A., Gong, Y., Li, Z., Wang, S., Yan, Q., Wang, D., Hou, B., & Zhang, C. (2022). Genome-Wide CRISPR/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma. International journal of biological sciences, 18(11), 4357?4371. https://doi.org/10.7150/ijbs.69969",https://pubmed.ncbi.nlm.nih.gov/35864956/
18,3616780,T,"A,G",rs1791373,0.04065,1 x 10-8,-,DLGAP1,"DLGAP1 gene is targeted by microRNA-148a (miR-148a) in the context of glioblastoma (GBM). DLGAP1 is implicated in promoting the proliferation, growth, migration, invasion, and epithelial-mesenchymal transition (EMT) program of GBM cells. Additionally, miR-148a directly targets DLGAP1, suggesting its involvement in regulating GBM pathogenesis.","Li, Y., Li, W., Zeng, X., Tang, X., Zhang, S., Zhong, F., Peng, X., Zhong, Y., Rosol, T. J., Deng, X., Liu, Z., Peng, S., & Peng, X. (2019). The role of microRNA-148a and downstream DLGAP1 on the molecular regulation and tumor progression on human glioblastoma. Oncogene, 38(47), 7234?7248. https://doi.org/10.1038/s41388-019-0922-3",https://pubmed.ncbi.nlm.nih.gov/31477833/
17,48334138,A,G,rs9303542,-,5 x 10-15,1.14,SKAP1,"SKAP1 is upregulated in colorectal cancer (CRC), promoting cell proliferation, migration, and invasion. It is regulated by THUMPD3-AS1 through the miR-218-5p/SKAP1 axis, contributing to CRC progression.","Pu, Y., Wei, J., Wu, Y., Zhao, K., Wu, Y., Wu, S., Yang, X., & Xing, C. (2022). THUMPD3-AS1 facilitates cell growth and aggressiveness by the miR-218-5p/SKAP1 axis in colorectal cancer. Cell biochemistry and biophysics, 80(3), 483?494. https://doi.org/10.1007/s12013-022-01074-4",https://pubmed.ncbi.nlm.nih.gov/35538197/
17,48334138,A,G,rs9303542,-,6 x 10-9,1.12,SKAP1,"SKAP1 gene is implicated in the genetic predisposition to ovarian cancer, suggesting a potential role in the disease's development.","Goode, E. L., Chenevix-Trench, G., Song, H., Ramus, S. J., Notaridou, M., Lawrenson, K., Widschwendter, M., Vierkant, R. A., Larson, M. C., Kjaer, S. K., Birrer, M. J., Berchuck, A., Schildkraut, J., Tomlinson, I., Kiemeney, L. A., Cook, L. S., Gronwald, J., Garcia-Closas, M., Gore, M. E., Campbell, I., ? Ovarian Cancer Association Consortium (OCAC) (2010). A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature genetics, 42(10), 874?879. https://doi.org/10.1038/ng.668",https://pubmed.ncbi.nlm.nih.gov/20852632/
17,48184809,C,"G,T",rs2278868,-,5 x 10-7,1.1494253,SKAP1,"SKAP1 is upregulated in colorectal cancer (CRC), promoting cell proliferation, migration, and invasion. It is regulated by THUMPD3-AS1 through the miR-218-5p/SKAP1 axis, contributing to CRC progression.","Pu, Y., Wei, J., Wu, Y., Zhao, K., Wu, Y., Wu, S., Yang, X., & Xing, C. (2022). THUMPD3-AS1 facilitates cell growth and aggressiveness by the miR-218-5p/SKAP1 axis in colorectal cancer. Cell biochemistry and biophysics, 80(3), 483?494. https://doi.org/10.1007/s12013-022-01074-4",https://pubmed.ncbi.nlm.nih.gov/35538197/
17,48423311,T,C,rs7207826,-,1 x 10-14,1.13894,SKAP1,"SKAP1 gene is implicated as one of the genes whose expression may be influenced by DNA methylation levels associated with epithelial ovarian cancer (EOC) risk. Specifically, methylation at certain CpG sites may regulate the expression of SKAP1, along with other genes such as MAPT, HOXB3, ABHD8, and ARHGAP27, thereby influencing EOC risk. This suggests that SKAP1 may play a role in the genetic regulation of EOC susceptibility through DNA methylation-mediated gene expression modulation.","Yang, Y., Wu, L., Shu, X., Lu, Y., Shu, X. O., Cai, Q., Beeghly-Fadiel, A., Li, B., Ye, F., Berchuck, A., Anton-Culver, H., Banerjee, S., Benitez, J., Bjõrge, L., Brenton, J. D., Butzow, R., Campbell, I. G., Chang-Claude, J., Chen, K., Cook, L. S., ? Long, J. (2019). Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. Cancer research, 79(3), 505?517. https://doi.org/10.1158/0008-5472.CAN-18-2726",https://pubmed.ncbi.nlm.nih.gov/30559148/
17,48216874,C,"A,G",rs882380,-,1 x 10-8,1.11,SKAP1,"SKAP1 is the transcriptome-wide association study (TWAS) analyses for endometrial cancer susceptibility genes. It is highlighted as having biologically relevant tissue-specific expression associations, particularly in whole blood. SKAP1 may play a role in the genetic susceptibility to endometrial cancer, possibly through tissue-specific mechanisms.","Kho, P. F., Wang, X., CuÇllar-Partida, G., Dîrk, T., Goode, E. L., Lambrechts, D., Scott, R. J., Spurdle, A. B., O'Mara, T. A., & Glubb, D. M. (2021). Multi-tissue transcriptome-wide association study identifies eight candidate genes and tissue-specific gene expression underlying endometrial cancer susceptibility. Communications biology, 4(1), 1211. https://doi.org/10.1038/s42003-021-02745-3",https://pubmed.ncbi.nlm.nih.gov/34675350/
9,310970,G,"C,T",rs10969557,-,6 x 10-6,1.11,DOCK8,"DOCK8 encodes a protein involved in regulating various cellular processes such as migration, morphology, adhesion, and growth. Its down-regulation through genetic and epigenetic mechanisms, such as homozygous deletions and DNA methylation, has been implicated in the development and/or progression of lung cancer and potentially other cancers.","Takahashi, K., Kohno, T., Ajima, R., Sasaki, H., Minna, J. D., Fujiwara, T., Tanaka, N., & Yokota, J. (2006). Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. International journal of oncology, 28(2), 321?328.",https://pubmed.ncbi.nlm.nih.gov/16391785/
10,33497992,A,"C,G",rs141877527,-,1 x 10-6,1.9389111,NRP1,The NRP1 gene is highly expressed in prostate cancer cells and associated with poor prognosis. It promotes cancer cell proliferation and migration by interacting with EGFR and activating the AKT signaling pathway. Inhibition of NRP1 suppresses prostate cancer progression by blocking EGFR/AKT signaling.,"Zhang, P., Chen, L., Zhou, F., He, Z., Wang, G., & Luo, Y. (2023). NRP1 promotes prostate cancer progression via modulating EGFR-dependent AKT pathway activation. Cell death & disease, 14(2), 159. https://doi.org/10.1038/s41419-023-05696-1",https://pubmed.ncbi.nlm.nih.gov/36841806/
10,88435392,C,"A,T",rs1935581,-,7 x 10-9,1.05,RNLS,"The RNLS gene is associated with tumor heterogeneity in prostate cancer, particularly in relation to PTEN deletion. Its expression correlates with the degree of intratumor heterogeneity, impacting treatment response and clinical outcomes.","Yun, J. W., Lee, S., Ryu, D., Park, S., Park, W. Y., Joung, J. G., & Jeong, J. (2019). Biomarkers Associated with Tumor Heterogeneity in Prostate Cancer. Translational oncology, 12(1), 43?48. https://doi.org/10.1016/j.tranon.2018.09.003",https://pubmed.ncbi.nlm.nih.gov/30265975/
